Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.6%
    Check dated 2025-05-08T13:52:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T06:22:20.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-04-24T01:18:53.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial, while adding references to hematologic neoplasms and a new revision number.
    Difference
    8%
    Check dated 2025-04-16T20:37:45.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T14:41:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in terminology from 'Lymphosarcoma' to 'B-cell Lymphoma' and has been revised from version 2.14.2 to 2.14.3.
    Difference
    0.5%
    Check dated 2025-04-02T00:18:42.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.